Title
Category
Credits
Event date
Cost
Electronic Cigarettes and Vaping
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will provide an overview of the history, regulation and marketing of e-cigs, as well as the potential health and safety risks. It will also include counseling points for providers.
Treatment for Tobacco Use Disorder: A Focus on Medications
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will discuss prevalence, impact and treatment of tobacco use disorder. FDA-Approved medications for smoking cessation will be reviewed, including counseling points and access limitations.
Prescription Stimulant Misuse
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will provide information about prescription stimulant misuse. Current statistics of misuse will be presented. Vulnerable populations and rationale for misuse will be discussed. Signs and symptoms of misuse and abuse will be presented along with how to manage patients presenting with toxic effects of prescription stimulants.
Hidden (and Legal) Highs - Substances of Abuse You May Not Have Heard Of
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
A evaluation of non-traditional, legal, substances that are being misused and abused in the community to achieve legal intoxications.
Cannabis Use Disorder
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22. 
Opioid Use Disorder
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions.